“Some days I wake up and can’t feel how far we’ve appear,” stated Dr. Doblin, 67, who now oversees the Multidisciplinary Association for Psychedelic Scientific studies, a multimillion greenback study and advocacy empire that employs 130 neuroscientists, pharmacologists and regulatory professionals Functioning to lay the groundwork for the a